Abstract:Colorectal cancer (CRC) is the leading cause of cancer-related complications and deaths worldwide. Treatments currently being employed have limited use due to the off-target- side effects and minimum localized retention of the medicinal agents at the tumor site. This study aims to develop and evaluate a novel Hyd-Nano drug delivery system (HNDDS) capable of effective drug delivery in CRC. The HNDDS is composed of two parts; the first comprises surface-modified nanoparticles with folic acid to specifically target tumor cells. The second part is a pH-sensitive hydrogel encapsulating the surface-modified nanoparticles and providing a pH-sensitive and controlled drug release. The HNDDS was characterized via dynamic light scattering (DLS), Fourier transformed Infrared spectroscopy (FTIR), X-ray diffraction (XRD), thermogravimetric analysis (TGA)/diffraction scanning calorimetry (DSC) and scanning electron microscopy (SEM). In-vitro studies as sol-gel, porosity, drug loading, and entrapment efficacy etc. showed attractive results. The drug release study was conducted in simulated fluids (pH 7.4 and 1.2) using a dialysis membrane (10kDa) and the results displayed a pH-dependent drug release in a sustained manner for up to 70 hours. The pharmacokinetic profile (PK) was calculated using Kinetica® software that revealed Cmax as 621.83 + 1.94 and Tmax was increased up to 12 hours, similarly the calculated MRT was 14.52 ± 0.217 hours, and AUC was recorded as 7988.66 ± 221.68ng/mL*h. The DLS results depicted the size of synthesized nanoparticles as 122nm with PDI 0.21 and −31mV as zeta potential. Conjugation of Folic acid was estimated by UV–visible spectroscopy and the calculated amount in the sample was recorded as 15.94 ± 3.11 μg/mg. Cytotoxicity analysis for the developed HNDDS was conducted using Hela cells and IC50 values calculated for the HNDDS was 13.45μg/mL compared to 19.12 μg/mL and 23.11 μg/mL for nanoparticles and active drug respectively. The significant swelling, release, cytocompatibility, tumor cell specific endocytosis and sustained drug delivery achieved by the HNDDS makes it an ideal candidate to be used for cargoes in CRC.Graphical abstractDownload : Download high-res image (214KB)Download : Download full-size image

pH-sensitive docetaxel-loaded chitosan/thiolated hyaluronic acid polymeric nanoparticles for colorectal cancer

Bio-responsive<i> Bletilla</i><i> striata</i> polysaccharide-based micelles for enhancing intracellular docetaxel delivery (vol 142, pg 277, 2020)

Tumor targeting and pH-responsive polyelectrolyte complex nanoparticles based on hyaluronic acid-paclitaxel conjugates and Chitosan for oral delivery of paclitaxel

Polydopamine-Functionalized CA-(PCL-ran-PLA) Nanoparticles for Target Delivery of Docetaxel and Chemo-photothermal Therapy of Breast Cancer.

Ph-Sensitive Chitosan-Derived Nanoparticles As Doxorubicin Carriers for Effective Anti-Tumor Activity: Preparation and in Vitro Evaluation.

pH-sensitive nanoparticles of epigallocatechin-3-gallate in enhanced colorectal cancer therapy

Antitumor Drug Paclitaxel-loaded Ph-Sensitive Nanoparticles Targeting Tumor Extracellular Ph

Novel pH-triggered biocompatible polymeric micelles based on heparin-α-tocopherol conjugate for intracellular delivery of docetaxel in breast cancer

pH-responsive high stability polymeric nanoparticles for targeted delivery of anticancer therapeutics

CD44 targeted-chondroitin sulfate nanoparticles: Fine-tuning hydrophobic groups to enhance in vitro pH-responsiveness and in vivo efficacy for advanced breast cancer treatment

Dual pH-responsive and CD44 receptor targeted multifunctional nanoparticles for anticancer intracellular delivery

Fabrication and biological evaluation of chitosan coated hyaluronic acid-docetaxel conjugate nanoparticles in CD44+ cancer cells

A dual‐stimuli responsive supramolecular nanovector anchoring folic acid ligands for targeted delivery of anti‐colorectal drug hydroxycamptothecin

Overcoming drug resistance with a docetaxel and disulfiram loaded pH-sensitive nanoparticle

Synthesis of novel polymeric nanoparticles (methoxy-polyethylene glycol-chitosan/hyaluronic acid) containing 7-ethyl-10-hydroxycamptothecin for colon cancer therapy: in vitro, ex vivo and in vivo investigation

Dual pH/redox-responsive hyperbranched polymeric nanocarriers with TME-trigger size shrinkage and charge reversible ability for amplified chemotherapy of breast cancer

Innovative chitosan-polyacrylic acid-MoS 2 nanocomposite for enhanced and pH-responsive quercetin delivery

Poly(Lactic-co-Glycolic Acid Nanoparticles Loaded with Docetaxel and Coated with Chitosan, Carboxymethyl Chitosan, or Glycol Chitosan

Amphiphilic Polymeric Micelles Based on Deoxycholic Acid and Folic Acid Modified Chitosan for the Delivery of Paclitaxel

Folic acid-functionalized nanoparticles-laden biomaterials for the improved oral delivery of hydrophobic drug in colorectal cancer

Hyaluronidase and pH Dual-Responsive Nanoparticles for Targeted Breast Cancer Stem Cells